molecules can be made. This has been implemented in the case of a molecule rituximab, which has been glycol-engineered for enhancing its activity.(Isaac, 2009) References Akhtar, E, Bilal, S & Haque, U (2011) of Arthritis in India & Pakistan”, “Prevalence 33: 849-55 Rheumatology International, Bartold, PM, Marshall, RI and Haynes D.R (2005) & Rheumatoid Arthritis”, J “Peridontitis 76: 2066-74 Periodontal, AS, Braunwald, E, Kasper DL, Hauser, SL, Longo, DL, Jameson JL, Loscalzo, J. (2009) McGraw Hill: New York, 886-888 Harrison’s Manual Of Medicine. Hameed, K & Gibson, T (1997). comparison of the prevalence of rheumatoid arthritis and “A other rheumatic diseases amongst Pakistanis living in England & Pakistan”. British Journal of 36: 781-185 Rheumatology Hay, FC & Westwood MR Olwyn, (2002) 4th Edition. Blackwell Practical Immunology, Science: New York: 76 Isaacs, D John (2009) engineering to develop new antirheumatic therapies”, Arthritis “Antibody 11: 225-229 Research & Therapy. Nakaoka, H, Cui, T, Tajima A, Oka, A, Mitsunaga, S, Kashiwase, K, Y, Sato, S, Suzuki, Y, Inoko, H & Inoue, I (2011) A systems genetics approach provides a bridge from discovered “ genetic variants to biological pathways in rheumatoid arthritis”. 9: 1-16 PLoS One: Takeuchi, T (2011) change in rheumatoid arthritis management with biological “Revolutionary therapy” 60: 75-81 Keio Med Web Resource Used: Statistics of RA in Pakistan: On immunoassay of RA: Figures from:
molecules can be made. This has been implemented in the case of a molecule rituximab, which has been glycol-engineered for enhancing its activity.(Isaac, 2009) References Akhtar, E, Bilal, S & Haque, U (2011) “Prevalence of Arthritis in India & Pakistan”, Rheumatology International, 33: 849-55 Bartold, PM, Marshall, RI and Haynes D.R (2005) “Peridontitis & Rheumatoid Arthritis”, J Periodontal, 76: 2066-74 AS, Braunwald, E, Kasper DL, Hauser, SL, Longo, DL, Jameson JL, Loscalzo, J. (2009) Harrison’s Manual Of Medicine. McGraw Hill: New York, 886-888 Hameed, K & Gibson, T (1997). “A comparison of the prevalence of rheumatoid arthritis and other rheumatic diseases amongst Pakistanis living in England & Pakistan”. British Journal of Rheumatology 36: 781-185 Hay, FC & Westwood MR Olwyn, (2002) Practical Immunology, 4th Edition. Blackwell Science: New York: 76 Isaacs, D John (2009) “Antibody engineering to develop new antirheumatic therapies”, Arthritis Research & Therapy. 11: 225-229 Nakaoka, H, Cui, T, Tajima A, Oka, A, Mitsunaga, S, Kashiwase, K, Y, Sato, S, Suzuki, Y, Inoko, H & Inoue, I (2011) “ A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis”. PLoS One: 9: 1-16 Takeuchi, T (2011) “Revolutionary change in rheumatoid arthritis management with biological therapy” Keio Med 60: 75-81 Web Resource Used: Statistics of RA in Pakistan: On immunoassay of RA: Figures from: